2026
- The association between hair cortisol levels, Epstein-Barr virus infections and chronic fatigue in adolescents. Kongsnes BEB, Asprusten TT, Wyller VBB, Pedersen M.Stress. 2026 Dec 31;29(1):2638303. doi: 10.1080/10253890.2026.2638303. Epub 2026 Mar 2. PMID: 41772810.
- Charting the circulating proteome in ME/CFS using cross-system profiling to uncover mechanistic insights. Hoel A, Hoel F, Dyrstad SE, Chapola H, Rekeland IG, Risa K, Alme K, Sørland K, Brokstad KA, Marti HP, Mella O, Fluge Ø, Tronstad KJ.
Epub 2026 Mar 4. PMID: 41785863; PMCID: PMC13006441.
- Incidence age is bimodal for myalgic encephalomyelitis/chronic fatigue syndrome, with higher severity burden for early onset disease.McGrath SJ, Hillier CB, Dibble JJ, Schei T, Angelsen A, Ryback AA. Oxf Open Immunol. 2026 Mar 17;7(1):iqag007. doi: 10.1093/oxfimm/iqag007. PMID: 41983041; PMCID: PMC13070794.
- Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3rd International Conference of the Charité Fatigue Center.Fehrer A, Windzio L, Schoening S, Steiner S, Aschenbrenner AC, Babel N, Behrends U, Bellmann-Strobl J, Cammà G, Cash A, Doehner W, den Dunnen J, Fluge Ø, Franke C, Hoffmann K, Kedor C, Kim L, Löhden W, Mella O, Mihatsch LL, Peluso MJ, Puta C, Putrino D, Ramoji A, Sato W, Sawitzki B, Schlieper G, Schoenfeld Y, Seifert M, Sigurdsson F, Slaghekke A, Sommerfelt K, Sotzny F, Stein E, Steinacker JM, Stingl M, Systrom DM, Tronstad KJ, Wirth K, Wörmann B, Wüst RCI, Yamamura T, Scheibenbogen C. 2026 May;25(5):104043. doi: 10.1016/j.autrev.2026.104043. Epub 2026 Mar 25. PMID: 41895458.
2025
- The term functional disorders should be revitalised. Helgeland H, Getz LO, Herner LB, Bøen E, Myren STidsskr Nor Laegeforen. 2025 Feb 11;145(2)PMID: 39932085
- Predictors of fatigue progression in long COVID among young people. Brodwall EM, Selvakumar J, Havdal LB, Sommen S, Berven LL, Cvejic E, Bratholm Wyller VB, Pedersen MBrain Behav Immun Health. 2025 May;45:100982PMID: 40212283
- Patients with severe ME/CFS need hope and expert multidisciplinary care. Miller A, Symington F, Garner P, Pedersen MBMJ. 2025 May 14;389:r977PMID: 40368436
- Pasienter med funksjonelle lidelser trenger et bedre behandlingstilbud.Helgeland H, Boye B, Kristiansen H, Tangen MK, Høifødt HSH, Herner LB, Sagabråten SO, Karlsen KE, Diseth THTidsskr Nor Laegeforen. 2025 Jun 24;145(8)PMID: 40575824
- SMPDL a novel biomarker ans therapeutic target in myalgic encephalomyelitisRostami-Afshari B, Elremaly W, Franco A, Elbakry M, Akoume MY, Boufaied I, Moezzi A, Leveau C, Rompré P, Godbout C, Mella O, Fluge Ø, Moreau A.Transl Med. 2025 Jul 7;23(1):748. doi: 10.1186/s12967-025-06829-0. Erratum in: J Transl Med. 2025 Aug 14;23(1):911. doi: 10.1186/s12967-025-06900-w. PMID: 40624584; PMCID: PMC12236014.
- Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome-a clinical pilot study. Fluge Ø, Rekeland IG, Sørland K, Alme K, Risa K, Bruland O, Tronstad KJ, Mella O. PMID: Front Med (Lausanne). 2025 Jul 9;12:1607353. doi: 10.3389/fmed.2025.1607353. Erratum in: Front Med (Lausanne). 2025 Aug 18;12:1677216. doi: 10.3389/fmed.2025.1677216. PMID: 40703261; PMCID: PMC12283730.
- Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis. Rostami-Afshari B, Elremaly W, Franco A, Elbakry M, Akoume MY, Boufaied I, Moezzi A, Leveau C, Rompré P, Godbout C, Mella O, Fluge Ø, Moreau A. J Transl Med. 2025 Aug 14;23(1):911. doi: 10.1186/s12967-025-06900-w. Erratum for: J Transl Med. 2025 Jul 7;23(1):748. doi: 10.1186/s12967-025-06829-0. PMID: 40813669; PMCID: PMC12355754.
- Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS Ramadan DJ, Kichula KM, Tao S, Porfilio T, Lande A, Fluge Ø, Mella O, Strand EB, Saugstad OD, Norman PJ, Lie BA, Viken MK. Nov;130:106098. doi: 10.1016/j.bbi.2025.106098. Epub 2025 Aug 31. PMID: 40897283.
- Altered effort and deconditioning are not valid explanations of myalgic encephalomyelitis/chronic fatigue syndrome.Davenport TE, Scheibenbogen C, Zinn MA, Dimmock M, Stone J, Tronstad KJ, Fluge Ø, Bergquist J, Stevens SR, Tuller D, Behrends U, Van Ness JM, Vink MA, Nacul L. 2025 Oct 17;16(1):9176. doi: 10.1038/s41467-025-64538-0. PMID: 41107289; PMCID: PMC12534454.
- Folkehelseinstituttet – oppsummerer forskning og erfaringer fra behandlingstilbud for langvarig utmattelse uten klar medisinsk årsak.FHI (2025): Pasienters erfaringer med behandling av langvarig utmattelse av uklar årsak
2024
- Innflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggresive B cell lymphomas Arffman M, Meriranta L, Autio M, Holte H, Jørgensen J, Brown P, Jyrkkiö S, Jerkeman M, Drott K, Fluge Ø, Björkholm M, Karjalainen-Lindsberg ML, Beiske K, Pedersen MØ, Leivonen SK, Leppä S. Med. 2024 Jun 14;5(6):583-602.e5. doi: 10.1016/j.medj.2024.03.007. Epub 2024 Apr 4. PMID: 38579729.
- Assessing Functional Capacity in Myalgic Encephalopathy/Chronic Fatigue Syndrome: A Patient-Informed Questionnaire Kristian Sommerfelt, Trude Schei, Katharine A Seton, Simon R Carding. J Clin Med. 2024 Jun 14;13(12):3486. doi: 10.3390/jcm13123486. PMID: 38930014; PMCID: PMC11204454.
- Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Ingrid G Rekeland, Kari Sørland, Lisbeth Lykke Neteland, Alexander Fosså, Kine Alme, Kristin Risa, Olav Dahl, Kari J Tronstad, Olav Mella, Øysten Fluge. PLoS One. 2024 Jul 23;19(7):e0307484. doi: 10.1371/journal.pone.0307484. PMID: 39042627; PMCID: PMC11265720.
- Brief Outpatient Rehabilitation Program for Post-Covid1-19 Condition: A randomized Clinical Trial Nerli TF, Selvakumar J, Cvejic E, Heier I, Pedersen JAMA Netw Open. 2024 Dec 2;7(12):e2450744. doi: 10.1001/jamanetworkopen.2024.50744. PMID: 39699896; PMCID: PMC11659907.
2023
- Endothelial dysfunction in ME/CFS patients Sandvik MK, Sørland K, Leirgul E, Rekeland IG, Stavland CS, Mella O, Fluge Ø. Endothelial dysfunction in ME/CFS patients. PLoS One. 2023 Feb 2;18(2):e0280942. doi: 10.1371/journal.pone.0280942. PMID: 36730360; PMCID: PMC9894436.
- Gastric dysmotility and gastrointestinal symptoms in ME/CFS Steinsvik EK, Hausken T, Fluge Ø, Mella O, Gilja OH. Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. Scand J Gastroenterol. 2023 Jul;58(7):718-725. doi: 10.1080/00365521.2023.2173533. Epub 2023 Feb 2. PMID: 36728717.
- Severe and Very Severe ME/CFS in Norway: Symptom Burden and Access to Care Sommerfelt K, Schei T, Angelsen A. Severe and Very Severe Myalgic Encephalopathy/Chronic Fatigue Syndrome ME/CFS in Norway: Symptom Burden and Access to Care. J Clin Med. 2023 Feb 13;12(4):1487. doi: 10.3390/jcm12041487. PMID: 36836022; PMCID: PMC9963221.
- Understanding, diagnosing, and treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – State of the art: Report of the 2nd international meeting at the Charité Fatigue Center Steiner S, Fehrer A, Hoheisel F, Schoening S, Aschenbrenner A, Babel N, Bellmann-Strobl J, Finke C, Fluge Ø, Froehlich L, Goebel A, Grande B, Haas JP, Hohberger B, Jason LA, Komaroff AL, Lacerda E, Liebl M, Maier A, Mella O, Nacul L, Paul F, Prusty BK, Puta C, Riemekasten G, Ries W, Rowe PC, Sawitzki B, Shoenfeld Y, Schultze JL, Seifert M, Sepúlveda N, Sotzny F, Stein E, Stingl M, Ufer F, Veauthier C, Westermeier F, Wirth K, Wolfarth B, Zalewski P, Behrends U, Scheibenbogen C. Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité Fatigue Center. Autoimmun Rev. 2023 Nov;22(11):103452. doi: 10.1016/j.autrev.2023.103452. Epub 2023 Sep 22. PMID: 37742748.
- Corrigendum: Cognitive behavioral therapy improves physical function and fatigue in mild and moderate chronic fatigue syndrome…Gotaas ME, Stiles TC, Bjørngaard JH, Borchgrevink PC, Fors EA. 2023 Mar 13;13:1122220. doi: 10.3389/fpsyt.2022.1122220. Erratum for: Front Psychiatry. 2021 Apr 12;12:580924. doi: 10.3389/fpsyt.2021.580924. PMID: 36994226; PMCID: PMC10041654.
- Chronic fatigue syndromes: real illnesses that people can recover from Oslo Chronic Fatigue Consortium; Alme TN, Andreasson A, Asprusten TT, Bakken AK, Beadsworth MB, Boye B, Brodal PA, Brodwall EM, Brurberg KG, Bugge I, Chalder T, Due R, Eriksen HR, Fink PK, Flottorp SA, Fors EA, Jensen BF, Fundingsrud HP, Garner P, Havdal LB, Helgeland H, Jacobsen HB, Johnson GE, Jonsjö M, Knoop H, Landmark L, Launes G, Lekander M, Linnros H, Lindsäter E, Liira H, Linnestad L, Loge JH, Lyby PS, Malik S, Malt UF, Moe T, Norlin AK, Pedersen M, Pignatiello SE, Rask CU, Reme SE, Roksund G, Sainio M, Sharpe M, Thorkildsen RF, van Roy B, Vandvik PO, Vogt H, Wyller HB, Wyller VBB. Scand J Prim Health Care. 2023 Dec;41(4):372-376. doi: 10.1080/02813432.2023.2235609. Epub 2023 Nov 29. PMID: 37740918; PMCID: PMC11001335.
- Endothelial dysfunction in ME/CFS patients Sandvik MK, Sørland K, Leirgul E, Rekeland IG, Stavland CS, Mella O, Fluge Ø. Endothelial dysfunction in ME/CFS patients. PLoS One. 2023 Feb 2;18(2):e0280942. doi: 10.1371/journal.pone.0280942. PMID: 36730360; PMCID: PMC9894436.
2022
- Activity monitoring and patient-reported outcome measures in ME/CFS patients Rekeland IG, Sørland K, Bruland O, Risa K, Alme K, Dahl O, Tronstad KJ, Mella O, Fluge Ø. PLoS One. 2022 Sep 19;17(9):e0274472. doi: 10.1371/journal.pone.0274472. PMID: 36121803; PMCID: PMC9484698.
- Genetic association study in ME/CFS identifies several potential risk loci Hajdarevic R, Lande A, Mehlsen J, Rydland A, Sosa DD, Strand EB, Mella O, Pociot F, Fluge Ø, Lie BA, Viken MK. Brain Behav Immun. 2022 May;102:362-369. doi: 10.1016/j.bbi.2022.03.010. Epub 2022 Mar 19. PMID: 35318112.
- No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Ueland M, Hajdarevic R, Mella O, Strand EB, Sosa DD, Saugstad OD, Fluge Ø, Lie BA, Viken MK.Transl Psychiatry. 2022 Jul 11;12(1):277. doi: 10.1038/s41398-022-02046-1. PMID: 35821115; PMCID: PMC9276688.
- Subjective and objective cognitive function in adolescent with chronic fatigue following Epstein-Barr virus infection. Øie MG, Rødø ASB, Bølgen MS, Pedersen M, Asprusten TT, Wyller VBB.Res. 2022 Dec;163:111063. doi: 10.1016/j.jpsychores.2022.111063. Epub 2022 Oct 17. PMID: 36327530.
2021
- Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Fluge Ø, Tronstad KJ, Mella O. PMID: 34263741; PMCID: PMC8279575.
- A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
- Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Results From Open-Label Cyclophosphamide Intervention Study
- Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci
- Cognitive Behavioral Therapy Improves Physical Function and Fatigue in Mild and Moderate Chronic Fatigue Syndrome: A Consecutive Randomized Controlled Trial of Standard and Short Interventions
- Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and Fatigue. Fevang B, Wyller VBB, Mollnes TE, Pedersen M, Asprusten TT, Michelsen A, Ueland T, Otterdal K.Front Immunol. 2021 Dec 20;12:715102. doi: 10.3389/fimmu.2021.715102. PMID: 34987499; PMCID: PMC8721200.
2020
- Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
- Pain in adolescent chronic fatigue following Epstein-Barr virus infection.Scand J Pain. 2020 Oct 25;20(4):765-773. doi: 10.1515/sjpain-2020-0031. PMID: 32892183.
- Cognitive-behavioural therapy combined with music therapy for chronic fatigue following Epstein-Barr virus infection in adolescents: a randomised controlled trial. Malik S, Asprusten TT, Pedersen M, Mangersnes J, Trondalen G, van Roy B, Skovlund E, Wyller VB.BMJ Paediatr Open. 2020 Oct 21;4(1):e000797. doi: 10.1136/bmjpo-2020-000797. PMID: 33117895; PMCID: PMC7580073.
2019
- Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome
- B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
- Searching for Serum Antibodies to Neuronal Proteins in Patients With Myalgic Encephalopathy/Chronic Fatigue Syndrome
- Lifestyle factors during acute Epstein-Barr virus infection in adolescents predict physical activity six months later.Pedersen M, Asprusten TT, Godang K, Leegaard TM, Osnes LT, Skovlund E, Tjade T, Øie MG, Wyller VBB.Acta Paediatr. 2019 Aug;108(8):1521-1526. doi: 10.1111/apa.14728. Epub 2019 Feb 17. PMID: 30685875.
- Fatigue in Epstein-Barr virus infected adolescents and healthy controls: A prospective multifactorial association study. Pedersen M, Asprusten TT, Godang K, Leegaard TM, Osnes LT, Skovlund E, Tjade T, Øie MG, Wyller VBB. J Psychosom Res. 2019 Jun;121:46-59. doi: 10.1016/j.jpsychores.2019.04.008. Epub 2019 Apr 10. PMID: 31003854.
- EBV-requisitioning physicians' guess on fatigue state 6 months after acute EBV infection. Asprusten TT, Pedersen M, Skovlund E, Wyller VB.BMJ Paediatr Open. 2019 Mar 1;3(1):e000390. doi: 10.1136/bmjpo-2018-000390. PMID: 30957026; PMCID: PMC6422241.
- Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study. Kristiansen MS, Stabursvik J, O'Leary EC, Pedersen M, Asprusten TT, Leegaard T, Osnes LT, Tjade T, Skovlund E, Godang K, Wyller VBB. Brain Behav Immun. 2019 Aug;80:551-563. doi: 10.1016/j.bbi.2019.04.040. Epub 2019 Apr 27. PMID: 31039432.
- Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study. Pedersen M, Asprusten TT, Godang K, Leegaard TM, Osnes LT, Skovlund E, Tjade T, Øie MG, Wyller VBB. Brain Behav Immun. 2019 Jan;75:94-100. doi: 10.1016/j.bbi.2018.09.023. Epub 2018 Sep 25. PMID: 30261303.
2018
- Kronisk utmattelsessyndrom og pyruvat dehydrogenasefunksjon
- Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study
2017
- Sleep-wake rhythm disturbances and perceived sleep in adolescent chronic fatigue syndrome. Pedersen M, Ekstedt M, Småstuen MC, Wyller VB, Sulheim D, Fagermoen E, Winger A, Pedersen E, Hrubos-Strøm H. J Sleep Res. 2017 Oct;26(5):595-601. doi: 10.1111/jsr.12547. Epub 2017 May 4. PMID: 28470767.
2016
- Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome
- Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome
2015
2009
Sist oppdatert 27.05.2026